DE602005011879D1 - Verfahren zur Herstellung von O-alkylierten Rapamycinderivaten - Google Patents

Verfahren zur Herstellung von O-alkylierten Rapamycinderivaten

Info

Publication number
DE602005011879D1
DE602005011879D1 DE200560011879 DE602005011879T DE602005011879D1 DE 602005011879 D1 DE602005011879 D1 DE 602005011879D1 DE 200560011879 DE200560011879 DE 200560011879 DE 602005011879 T DE602005011879 T DE 602005011879T DE 602005011879 D1 DE602005011879 D1 DE 602005011879D1
Authority
DE
Germany
Prior art keywords
reaction
preparation
rapamycin derivatives
alkylrapamycin
alkylated rapamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE200560011879
Other languages
English (en)
Inventor
Masashi Isozaki
Tetsuro Kawanishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Publication of DE602005011879D1 publication Critical patent/DE602005011879D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
DE200560011879 2004-03-01 2005-02-16 Verfahren zur Herstellung von O-alkylierten Rapamycinderivaten Active DE602005011879D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004056233 2004-03-01

Publications (1)

Publication Number Publication Date
DE602005011879D1 true DE602005011879D1 (de) 2009-02-05

Family

ID=34747599

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200560011879 Active DE602005011879D1 (de) 2004-03-01 2005-02-16 Verfahren zur Herstellung von O-alkylierten Rapamycinderivaten

Country Status (6)

Country Link
US (2) US7193078B2 (de)
EP (1) EP1571151B1 (de)
JP (2) JP4267053B2 (de)
AT (1) ATE418559T1 (de)
DE (1) DE602005011879D1 (de)
ES (1) ES2315745T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4080337B2 (ja) 2001-03-22 2008-04-23 松下電器産業株式会社 正極活物質およびこれを含む非水電解質二次電池
JP4510331B2 (ja) 2001-06-27 2010-07-21 パナソニック株式会社 非水電解質二次電池
US8658125B2 (en) 2001-10-25 2014-02-25 Panasonic Corporation Positive electrode active material and non-aqueous electrolyte secondary battery containing the same
US8241790B2 (en) 2002-08-05 2012-08-14 Panasonic Corporation Positive electrode active material and non-aqueous electrolyte secondary battery containing the same
EP2090580B1 (de) * 2006-11-27 2014-06-04 Terumo Kabushiki Kaisha Verfahren zur herstellung eines o-alkylierten rapamycinderivats, und o-alkyliertes rapamycinderivat
WO2009131631A1 (en) * 2008-04-14 2009-10-29 Poniard Pharmaceuticals, Inc. Rapamycin analogs as anti-cancer agents
TW200948361A (en) * 2008-05-26 2009-12-01 Chunghwa Chemical Synthesis & Biotech Co Ltd Method for synthesizing Biolimus A9 and the like and method for improving stability of the same
WO2011059216A2 (ko) * 2009-11-10 2011-05-19 가톨릭대학교 산학협력단 광감작제가 코팅된 의료용 스텐트 및 이의 제조방법
KR101200210B1 (ko) * 2009-11-10 2012-11-09 가톨릭대학교 산학협력단 광감작제가 코팅된 의료용 스텐트 및 이의 제조방법
CN103140494A (zh) 2010-08-04 2013-06-05 美利奴生命科学有限公司 制备具有抗增殖特性的新的42-o-（杂烷氧基烷基）雷帕霉素化合物的方法
CN102174053B (zh) * 2011-03-09 2014-04-16 成都雅途生物技术有限公司 依维莫司的纯化方法
EP2589383A1 (de) 2011-11-06 2013-05-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin FKBP-subtypspezifisches Rapamycin-Analogon zur Verwendung bei der Behandlung von Erkrankungen
ES2645951T3 (es) * 2013-01-22 2017-12-11 Biosensors International Group, Ltd. Síntesis a baja temperatura de derivados de rapamicina
CN109651396B (zh) 2013-06-20 2021-09-14 诺华股份有限公司 氟代烷基磺酸烷基酯的烷基化
CN113620978A (zh) 2014-09-11 2021-11-09 加利福尼亚大学董事会 mTORC1抑制剂
WO2019212990A1 (en) 2018-05-01 2019-11-07 Revolution Medicines, Inc. C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors
JP7381492B2 (ja) 2018-05-01 2023-11-15 レヴォリューション・メディスンズ，インコーポレイテッド Ｍｔｏｒ阻害剤としてのｃ２６－連結ラパマイシン類似体
CN108676014A (zh) * 2018-06-15 2018-10-19 国药集团川抗制药有限公司 纯化依维莫司中间体的方法以及制备依维莫司的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516781A (en) * 1992-01-09 1996-05-14 American Home Products Corporation Method of treating restenosis with rapamycin
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds
US6939376B2 (en) * 2001-11-05 2005-09-06 Sun Biomedical, Ltd. Drug-delivery endovascular stent and method for treating restenosis
US7220755B2 (en) * 2003-11-12 2007-05-22 Biosensors International Group, Ltd. 42-O-alkoxyalkyl rapamycin derivatives and compositions comprising same
US7303758B2 (en) * 2004-01-20 2007-12-04 Cordis Corporation Local vascular delivery of mycophenolic acid in combination with rapamycin to prevent restenosis following vascular injury

Also Published As

Publication number Publication date
ATE418559T1 (de) 2009-01-15
EP1571151B1 (de) 2008-12-24
US20070160646A1 (en) 2007-07-12
JP2008273976A (ja) 2008-11-13
US7193078B2 (en) 2007-03-20
ES2315745T3 (es) 2009-04-01
JP5004941B2 (ja) 2012-08-22
JP2009136686A (ja) 2009-06-25
EP1571151A1 (de) 2005-09-07
US20050192311A1 (en) 2005-09-01
JP4267053B2 (ja) 2009-05-27

Similar Documents

Publication Publication Date Title
DE602005011879D1 (de) Verfahren zur Herstellung von O-alkylierten Rapamycinderivaten
AU2007282148B2 (en) Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines
WO2007041167A3 (en) Process for production of delta-9-tetrahydrocannabinol
DE60124692D1 (de) Verfahren zur herstellung von optisch-aktiven sulfoxid-derivaten
DE60311599D1 (de) Verfahren zur herstellung von duloxetin und deren verwendeten zwischenprodukten
ATE533775T1 (de) Verfahren zur herstellung von 17-vinyl-triflaten als intermediate
KR101432866B1 (ko) 생활성 화합물의 설폭사이드화 방법
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE490956T1 (de) Verfahren zur herstellung eines 2- ethylaminopyridinderivats
EP1787983A4 (de) Verfahren zur herstellung von isoindolderivaten
ATE422200T1 (de) Verfahren zur herstellung substituierter nikotinsäureester
WO2006112742A3 (en) PROCESS FOR PREPARATION OF 13,14-DIHYDRO-PGF2α DERIVATIVES
ATE423764T1 (de) Verfahren zur herstellung von hydrazon-derivaten
DE602005021461D1 (de) Verfahren zur herstellung von cabergolin
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
NO20063058L (no) Fremgangsmate for fremstilling av (3-okso-2,3-dihydro-1H-isoindol-1-yl)acetylguanidinderivater
DE60037766D1 (de) Verfahren zur Herstellung von 2-Alkyl-3-aminothiophen Derivate und 3-Aminothiophen Derivate
DE602006015458D1 (de) Verfahren zur herstellung eines carbonsäureamidderivats
EP1375487A4 (de) Verfahren zur herstellung von chinolin?3?carbonsäureverbindungen
DE60008334D1 (de) Verfahren zur herstellung von 3-hydroxy-tetrahydrofuran
ATE353877T1 (de) Verfahren zur herstellung von monoifluorierten pyridinyl- und pyrimidinyl-beta-ketoestern
ATE417043T1 (de) Verfahren zur herstellung von imiquimod und dessen zwischenverbindungen
CA2454015C (en) A process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives
FR2854402B1 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroides
ATE387423T1 (de) Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition